BIH Stem Cell Lecture

(Informationen nur in Englisch verfügbar)

While the use of human induced pluripotent stem cells (iPSCs) in regenerative medicine is a long-term goal, a growing body of studies has shown promising results in the fields of drug discovery, development, and toxicity screening. Specifically, recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. In the lecture Professor Wu will discuss recent advances in this technology in the cardiovascular field.

 

Date

29 August 2016 | 4:00 pm

Venue

Auditorium CharitéCrossOver (CCO), Campus Charité Mitte (Virchowweg 6, 10177 Berlin)

No registration required.